HOME >> MEDICINE >> NEWS
Bone cement only controls bacteria for a few days after the operation

Dutch research has revealed that bone cement containing antibiotics can effectively control infections around prostheses but only during the first few days after the implantation. For the past 30 years bone cement, which affixes hip and knee prostheses to the bone, has contained antibiotics and from the start, the usefulness of this has been contested.

In a laboratory set-up, Hans Hendriks discovered that in the immediate vicinity of the antibiotic-containing bone cement, the antibiotic concentrations are particularly high. However, this is predominantly during the first few days after the application of the cement and the long-term release of the antibiotic seems to be less effective.

Hendriks investigated the release of antibiotics under simulated real-life conditions. He first of all investigated the antibiotic concentration in the cavity between the surface of the bone and the bone cement. In the human body this cavity is about 0.2 mm wide.

The antibiotic concentrations in the cavity were found to be 1000 times higher than the lethal dose for most bacteria. Experiments with different bacterial species led Hendriks to conclude that virtually no bacteria could survive in this environment. Three weeks later, the concentration of antibiotics had decreased to the extent that increasingly fewer bacteria were inhibited by these.

Placing the bone cement under stress did not affect the release of antibiotics. Walking on a cemented prosthesis results in the bone cement being subjected to periodic stress. Small cracks can arise as a consequence of this. As the surface of such a crack has not previously been in direct contact with body fluids it could form a new surface for the release of the antibiotic. Using an experimental set-up, Hendriks demonstrated that no new release occurs even after 5 to 10 years of walking around on a prosthesis.

For the past 30 years, bone cement has contained antibiotics to prevent and cure infections ar
'"/>

Contact: Sonja Jacobs
news@nwo.nl
31-703-440-713
Netherlands Organization for Scientific Research
10-Oct-2003


Page: 1 2

Related medicine news :

1. Growing your own replacement teeth? Not science fiction!
2. Is it ethical to use enhancement technologies to make us better than well?
3. Women taking breast enhancement pills swallow empty promises
4. Premature infants with lung disease may continue to need replacement substance to ease breathing
5. Biotech breakthrough in islet cell replacement for type 1 diabetes
6. MDCT is better than plain film in diagnosing hip replacement complications
7. For foster children, unstable placements have higher healthcare costs
8. Testosterone replacement improves muscle strength, function in HIV-infected women
9. Disc replacement in neck relieves pain, restores mobility
10. Minors able to buy nicotine replacement therapy products
11. Study finds no causal link between testosterone replacement, prostate cancer or cardiac disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bone cement only controls bacteria for few days after the operation

(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... patients who allegedly suffered serious, life-threatening episodes of internal bleeding ... federal litigation underway in U.S. District Court, Southern District of ... on the Court’s website, 818 Pradaxa side effect claims had ... 24, 2013. That’s up from 705 claims reported by ...
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 ... organization dedicated to brain cancer research and advocacy, comments ... for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma ... glioblastoma cells. , According to a Science ... for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
Cached News: